ROBERT MORE
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
DIRECTOR
DIRECTOR
DIRECTOR
JON B. BRUSS, ALAN B. COLOWICK, TROY COX, JOHN DOYLE, JOHN C. DOYLE, BECKI FILICE, MICHAEL FISCHBACH, IAN R. FRIEDLAND, HALLEY E. GILBERT, KENNETH J. HILLAN, JOHN F. HOLLWAY, DENNIS HOM, J. KEVIN JUDICE, THOMAS KING, KENT LIEGINGER, KENT E. LIEGINGER, GARY LOEB, HEINZ E. MOSER, KENNETH NUSSBACHER, BRYAN ROBERTS, BRYAN E. ROBERTS, SCOTT ROCKLAGE, CAMILLE SAMUELS, CAMILLE D. SAMUELS, ZERYN SARPANGAL, TOBIN C. SCHILKE, JOHN W. SMITHER, GREGORY STEA, LEE SWEM, CHRISTOPHER WALSH, CHRISTOPHER T. WALSH, CHRISTINE WELCH, BLAKE WISE
DIRECTOR
DIRECTOR
DAVID AMERSON, ROBERT K. ANDERSON, ANTON CLIFFORD, ROBERT W. CROCE, RYAN DRANT, ARTHUR FRANKEN, CHRISTOPHER GLEASON, JAMES LEECH, JOSHUA MAKOWER, SHAHZAD MALIK, MATT MCAVINEY, DAN MURRAY, JOHN NEHRA, HENRY A. PLAIN, HENRY A. PLAIN, JR., CHRISTOPHER SHEN, KEVIN K. SIDOW, DAVID VAN METER, MICHAEL WASSERMAN
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER, DIRECTOR
DIRECTOR
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2024-02-06
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2021-01-07
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-04-29
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2020-05-06

